3.4.3 Personal Conflict of Interest in Medical Research: What Is It? What Can Be Done About It?
Trudo Lemmens, LicJur, LLM, DCL
- To understand the concept of conflict of interest in the context of medical research
- To understand why conflicts of interest have to be addressed
- To learn what types of remedies exist to deal with conflicts of interest
Dr. Reed is an academic researcher with over 400 publications. He is on the advisory boards of professional organizations as well as pharmaceutical companies. He holds a Chair in Cardiology at the University of Port Hope. He obtained a contract from the pharmaceutical company Selaserom to conduct a phase 3 double-blind randomized controlled trial comparing Selaserom's drug Lovrux with another hypertension drug in the University of Port Hope's General Hospital. Dr. Reed has been paid as an expert consultant during the development of Lovrux. The contract provides a lump sum of $9,000 per patient to Dr. Reed and his team for all administrative and research-related costs, payment for research equipment and a half-time salary for a research coordinator. Dr. Reed will receive stock options in Selaserom. The contract stipulates that blood samples and clinical data will be analyzed at the General Hospital's research laboratory and that the data will be forwarded to Selaserom's research unit, which will keep the randomization codes. Selaserom will organize the final analysis and will coordinate, in collaboration with Dr. Reed, all public communications related to the project.
- What is a conflict of interest?
- How can we identify conflicts of interest in medical research?
- What are the primary professional obligations of researchers?
- What types of financial conflicts of interest exist in medical research?
- How can the professional obligations to conduct research and to protect the integrity and well-being of human subjects be affected by these financial interests?
- What remedies are there to deal with conflicts of interest?
- What conflicts of interest affect Dr. Reed?
- How should Dr. Reed's conflicts of interest be dealt with?
Q1. What is a conflict of interest?
Q2. How can we identify conflicts of interest in medical research?
Q2a. What are the primary professional obligations of researchers?
Q2b. What types of financial conflicts of interest exist in medical research?
Q2c. How can the professional obligations to conduct research and to protect the integrity and well-being of human subjects be affected by these financial interests?
Q3. What remedies are there to deal with conflicts of interest?
Q4. What conflicts of interest affect Dr. Reed?
Q5. How should Dr. Reed's conflicts of interest be dealt with?
There is a growing recognition, resulting in part from various empirical studies, that financial conflicts of interest can impact on the design, conduct, analysis and reporting of clinical research. It is also increasingly recognized that disclosure of conflicts of interests is not sufficient to deal with the potential impact on the protection of research subjects and the integrity of research. Dealing with such conflicts is complex, and various institutional and regulatory measures have been developed to address the problem. Researchers, institutions, governmental agencies and REBs have to work together to reduce the potential negative impact of conflicts of interests.
- World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. World Medical Association; 1964, as amended at the 59th WMA General Assembly, Seoul 2008. Available from: http://www.wma.net/e/policy/b3.htm
- College of Physicians and Surgeons of Ontario. Conflict of interest: recruitment of subjects for research studies, policy 6-06. College of Physicians and Surgeons of Ontario; 2006.
- Rochon PA, Hoey J, Chan A-W, Ferris LE, Lexchin J, et al., Financial Conflicts of Interest Checklist 2010 for Clinical Research Studies. Open Medicine 2010; 4(1): e69. Available online: http://www.openmedicine.ca/article/view/356/318
- Steinbrock R. Disclosure of Industry Payments to Physicians. N Engl J Med 2008 359: 559-561
- Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-council policy statement: ethical conduct for research involving humans. Ottawa: Public Works and Government Services Canada; 2010. Available from: http://www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf
- Association of American Medical Colleges. Protecting patients, preserving integrity, advancing health: accelerating the implementation of COI policies in human subjects research. A report of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research. 2008. Available from: http://www.aau.edu/WorkArea/showcontent.aspx?id=6822
- Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-council policy statement: ethical conduct for research involving humans. Ottawa: Public Works and Government Services Canada; 2010. Available from: http://www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf, Articles 11.3 and 11.12
- De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet 2005; 365: 1827–9.
- Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA: Journal of the American Medical Association 2003; 289: 454–65.
- Canadian Medical Association. CMA code of ethics (updated 2004). Ottawa: Canadian Medical Association; 2004. Available from: http://policybase.cma.ca/PolicyPDF/PD04-06.pdf
- Canadian Institutes of Health Research. Policy on access to research outputs. Ottawa: Canadian Institutes of Health Research; 2007. Available from: http://www.cihr-irsc.gc.ca/e/34846.html
- Canadian Medical Association. Guidelines for Physicians in Interactions With Industry [CMA Policy]. Ottawa: Canadian Medical Association; 2007. Available from: http://policybase.cma.ca/dbtw-wpd/Policypdf/PD08-01.pdf
- Hampson LA, Bekelman JE, Gross CP. Empirical data on conflicts of interest. In: Emanuel EJ, et al. The Oxford textbook of clinical research ethics. Oxford: Oxford University Press; 2008. pp. 767–79.
- Institute of Medicine (Committee on Assessing the System for Protecting Human Research Participants). Responsible research: a systems approach to protecting research participants. Washington, DC: National Academies Press; 2001.
- Kalb PE, Koehler KG. Legal issues in scientific research. JAMA: Journal of the American Medical Association 2001; 287: 85.
- Lemmens T, Luther L. Conflicts of interest of clinician-researchers. In: Singer PS, Viens A, editors. Cambridge textbook of bioethics. Cambridge: Cambridge University Press; 2008. pp. 222-230.
- Lemmens T, Miller PB. Regulating the market in human research participants, PLoS Medicine 2006; 3(8): e330.
- Lemmens T, Warring DR, editors. Law and ethics in biomedical research: regulation, conflict of interest, and liability. Toronto: University of Toronto Press; 2006.
- Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167–70.
- Office of Inspector General. Recruiting human subjects: pressures in industry-sponsored research. Washington, DC: US Department of Health and Human Services; 2000.
- Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib : a case study of industry documents from rofecoxib litigation. JAMA: Journal of the American Medical Association 2008; 299(15): 1800–12.
- Sismondo S. Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine 2007; 4(9): e286.
- Thompson DF. Understanding financial conflicts of interest. New England Journal of Medicine 1993; 8: 573–6.
- US Department of Health and Human Services. 21 CFR 56.107(e). Final guidance document: financial relationships and interests in research involving human subjects: guidance for human subject protection. 2004. Available from: http://www.hhs.gov/ohrp/humansubjects/finreltn/fguid.pdf
- World Health Organization. International clinical trials registry platform (ICTRP). World Health Organization; 2006. Available from: http://www.who.int/ictrp/en/